TEC-mediated TRF-31R9J Regulates Histone Lactylation and Acetylation by HDAC1 to Suppress Hepatocyte Ferroptosis and Improve Non-alcoholic Steatohepatitis

Overview

Journal Clin Epigenetics

Publisher Biomed Central

Date 2025 Jan 22

PMID 39838504

Authors

Juanjuan Zhu

Xian Wu

Mao Mu

Quan Zhang

Xueke Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Tectorigenin (TEC) is a monomer of anthocyanin, which we found exhibits hepatoprotective effects. tRNA-derived fragments (tRFs) and ferroptosis play important roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). Recent discoveries have revealed that histone lactylation and acetylation play a crucial role in connecting cellular metabolism and epigenetic regulation through post-translational modification of histones. However, it is unclear whether TEC improves NASH by regulating histone lactylation, acetylation and hepatocyte ferroptosis through tRFs.

Results: In this study, we demonstrated that TEC significantly inhibits free fatty acids-induced hepatocyte ferroptosis both in vitro and in vivo. We identified tRF-31R9J (tRF-31-R9JP9P9NH5HYD) involved in TEC regulation of ferroptosis in steatosis hepatocytes. Overexpression of tRF-31R9J suppressed hepatocyte ferroptosis and enhanced cell viability in steatosis HepG2 cells. Knockdown of tRF-31R9J partially counteracted the inhibitory effect of TEC on ferroptosis in hepatocytes. Mechanistically, tRF-31R9J recruited HDAC1 to reduce the levels of histone lactylation and acetylation modifications of the pro-ferroptosis genes ATF3, ATF4, and CHAC1, thereby inhibiting their gene expression.

Conclusions: This study demonstrates that TEC-mediated tRF-31R9J inhibits hepatocyte ferroptosis through HDAC1-regulated histone delactylation and deacetylation, thereby improving NASH. These discoveries offer a theoretical foundation and new strategies for the medical management of NASH.

References

Wang W, Zhu L, Li H, Ren W, Zhuo R, Feng C . Alveolar macrophage-derived exosomal tRF-22-8BWS7K092 activates Hippo signaling pathway to induce ferroptosis in acute lung injury. Int Immunopharmacol. 2022; 107:108690. DOI: 10.1016/j.intimp.2022.108690. View

Zhu J, Cheng M, Zhao X . A tRNA-derived fragment (tRF-3001b) aggravates the development of nonalcoholic fatty liver disease by inhibiting autophagy. Life Sci. 2020; 257:118125. DOI: 10.1016/j.lfs.2020.118125. View

Zhu J, Wen Y, Zhang Q, Nie F, Cheng M, Zhao X . The monomer TEC of blueberry improves NASH by augmenting tRF-47-mediated autophagy/pyroptosis signaling pathway. J Transl Med. 2022; 20(1):128. PMC: 8919551. DOI: 10.1186/s12967-022-03343-5. View

Rho H, Terry A, Chronis C, Hay N . Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis. Cell Metab. 2023; 35(8):1406-1423.e8. PMC: 11748916. DOI: 10.1016/j.cmet.2023.06.013. View

Fan X, Huang Y, Su Y, Chen S, Zhang Y, Huang W . Exploring the regulatory mechanism of tRNA-derived fragments 36 in acute pancreatitis based on small RNA sequencing and experiments. World J Gastroenterol. 2023; 29(30):4642-4656. PMC: 10472903. DOI: 10.3748/wjg.v29.i30.4642. View

Kuo Y, Ma C, Chen H, Chen Y, Lai Y, Liu H . A novel antisense RNA ASPACT confers multi-level suppression of PACT and associated signalling. RNA Biol. 2019; 16(9):1263-1274. PMC: 6693538. DOI: 10.1080/15476286.2019.1624471. View

Ren T, Zhu J, Zhu L, Cheng M . The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Nutrients. 2017; 9(3). PMC: 5372861. DOI: 10.3390/nu9030198. View

Ying S, Li P, Wang J, Chen K, Zou Y, Dai M . tRF-Gln-CTG-026 ameliorates liver injury by alleviating global protein synthesis. Signal Transduct Target Ther. 2023; 8(1):144. PMC: 10073094. DOI: 10.1038/s41392-023-01351-5. View

Zhou Y, Yang L, Liu X, Wang H . Lactylation may be a Novel Posttranslational Modification in Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy. Front Pharmacol. 2022; 13:926802. PMC: 9202888. DOI: 10.3389/fphar.2022.926802. View

10.

He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X . Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. Cell Rep. 2023; 42(2):112033. DOI: 10.1016/j.celrep.2023.112033. View

11.

Yamane D, Hayashi Y, Matsumoto M, Nakanishi H, Imagawa H, Kohara M . FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication. Cell Chem Biol. 2021; 29(5):799-810.e4. PMC: 8913804. DOI: 10.1016/j.chembiol.2021.07.022. View

12.

Yang J, Fernandez-Galilea M, Martinez-Fernandez L, Gonzalez-Muniesa P, Perez-Chavez A, Martinez J . Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. Nutrients. 2019; 11(4). PMC: 6521137. DOI: 10.3390/nu11040872. View

13.

Li X, Wang T, Huang X, Li Y, Sun T, Zang S . Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity. Liver Int. 2020; 40(6):1378-1394. DOI: 10.1111/liv.14428. View

14.

Xie B, Lin J, Chen X, Zhou X, Zhang Y, Fan M . CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol Cancer. 2023; 22(1):151. PMC: 10486081. DOI: 10.1186/s12943-023-01856-1. View

15.

Chu X, He C, Sang B, Yang C, Yin C, Ji M . Transfer RNAs-derived small RNAs and their application potential in multiple diseases. Front Cell Dev Biol. 2022; 10:954431. PMC: 9441921. DOI: 10.3389/fcell.2022.954431. View

16.

Schuster S, Cabrera D, Arrese M, Feldstein A . Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018; 15(6):349-364. DOI: 10.1038/s41575-018-0009-6. View

17.

Zhu J, Zhou M, Zhao X, Mu M, Cheng M . Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease via IL-22-mediated JAK1/STAT3/BAX signaling. Food Funct. 2018; 9(12):6298-6306. DOI: 10.1039/c8fo01227j. View

18.

Younossi Z, Anstee Q, Marietti M, Hardy T, Henry L, Eslam M . Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2017; 15(1):11-20. DOI: 10.1038/nrgastro.2017.109. View

19.

Moreno-Yruela C, Zhang D, Wei W, Baek M, Liu W, Gao J . Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022; 8(3):eabi6696. PMC: 8769552. DOI: 10.1126/sciadv.abi6696. View

20.

Qiao Y, Ji J, Hou W, Qu G, Li S, Li X . tRF3-IleAAT reduced extracellular matrix synthesis in diabetic kidney disease mice by targeting ZNF281 and inhibiting ferroptosis. Acta Pharmacol Sin. 2024; 45(5):1032-1043. PMC: 11053026. DOI: 10.1038/s41401-024-01228-5. View